SCHEMBL8724113

SCHEMBL8724113

c1cn(-c2sccc2-c2ccsc2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.42
CYP11B1 P15538 4/20 0.41
CYP11B2 P19099 4/20 0.41
CYP3A4 P08684 4/20 0.39
CYP2A6 P11509 3/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
FLT1 P17948 1/20 0.35
FLT4 P35916 1/20 0.35
KDR P35968 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK10 P53779 1/20 0.35
TSHR P16473 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALOX15 P16050 1/20 0.35
CYP1A2 P05177 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8720915 0.77 CYP17A1 (0.41) CYP17A1CYP11B1CYP11B2CYP3A4CYP2A6
SCHEMBL27457704 0.76 IDO1 (0.49) CYP17A1CYP11B1CYP11B2CYP3A4CYP2A6
SCHEMBL8724216 0.74 CYP11B1 (0.42) CYP17A1CYP11B1CYP11B2CYP3A4CYP2A6
SCHEMBL8721417 0.72 CYP11B1 (0.42) CYP17A1CYP11B1CYP11B2GAA
SCHEMBL8721409 0.72 IDO1 (0.46) CYP11B1CYP11B2CYP3A4CYP2A6CYP2C9
SCHEMBL3787426 0.70 LMNA (0.47) CYP11B1CYP11B2CYP3A4CYP2A6CYP2C9
SCHEMBL10614052 0.70 NOTUM (0.47) CYP3A4CYP2A6CYP2C9CYP2C19MAPK8
SCHEMBL8720894 0.70 MAPK8 (0.33) CYP3A4CYP2A6MAPK8MAPK10CYP1A2
SCHEMBL4236888 0.70 CYP3A4 (0.53) CYP11B1CYP11B2CYP3A4CYP2A6CYP2C9
SCHEMBL8721420 0.68 CYP17A1 (0.40) CYP17A1CYP11B1CYP11B2CYP3A4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998000430-A1 IMIDAZOL DERIVATIVES USEFUL AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-01-08 WO disclosed